Amedeo Smart

Free Medical Literature Service


 

Amedeo

Stroke

  Free Subscription

Articles published in
Circulation
    July 2022
  1. KUEHN BM
    Nurse Navigators Cut Stroke Readmissions by Half.
    Circulation. 2022;146:140-141.
    >> Share

  2. HANKEY GJ
    Endovascular Therapy for Acute Basilar Artery Occlusion.
    Circulation. 2022;146:18-20.
    >> Share

    June 2022
  3. HAGSTROM E, Steg PG, Szarek M, Bhatt DL, et al
    Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
    Circulation. 2022 Jun 30:101161CIRCULATIONAHA121057807.
    >> Share

  4. ABDEL-QADIR H, Akioyamen LE, Fang J, Pang A, et al
    Association of Neighborhood-Level Material Deprivation With Atrial Fibrillation Care in a Single-Payer Health Care System: A Population-Based Cohort Study.
    Circulation. 2022 Jun 9:101161CIRCULATIONAHA122058949.
    >> Share

  5. TAO C, Qureshi AI, Yin Y, Li J, et al
    Endovascular Treatment Versus Best Medical Management in Acute Basilar Artery Occlusion Strokes: Results From the ATTENTION Multicenter Registry.
    Circulation. 2022 Jun 3:101161CIRCULATIONAHA121058544.
    >> Share

    April 2022
  6. NATALE A, Kar S, Holmes D
    Letter by Natale et al Regarding Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
    Circulation. 2022;145:e847-e848.
    >> Share

  7. PRICE MJ, Gibson DN, Kar S
    Letter by Price et al Regarding the Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
    Circulation. 2022;145:e849.
    >> Share

  8. DHRUVA SS, Redberg RF
    Letter by Dhruva and Redberg Regarding Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
    Circulation. 2022;145:e845-e846.
    >> Share

  9. LUSEBRINK E, Kellnar A, Krieg K, Binzenhofer L, et al
    Percutaneous Transvalvular Microaxial Flow Pump Support in Cardiology.
    Circulation. 2022;145:1254-1284.
    >> Share

  10. VASAN RS, Enserro DM, Xanthakis V, Beiser AS, et al
    Temporal Trends in the Remaining Lifetime Risk of Cardiovascular Disease Among Middle-Aged Adults Across 6 Decades: The Framingham Study.
    Circulation. 2022 Apr 18. doi: 10.1161/CIRCULATIONAHA.121.057889.
    >> Share

  11. SPYROPOULOS AC, Raskob GE, Cohen AT, Ageno W, et al
    Association of Bleeding Severity with Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials.
    Circulation. 2022 Apr 7. doi: 10.1161/CIRCULATIONAHA.121.057847.
    >> Share

    March 2022
  12. BORLAUG BA, Blair J, Bergmann MW, Bugger H, et al
    Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure.
    Circulation. 2022 Mar 31. doi: 10.1161/CIRCULATIONAHA.122.059486.
    >> Share

  13. JOUNDI RA, Sun JL, Xian Y, Alhanti B, et al
    Association Between Endovascular Therapy Time to Treatment and Outcomes in Patients With Basilar Artery Occlusion.
    Circulation. 2022;145:896-905.
    >> Share

  14. LI KC, Huang L, Tian M, Di Tanna GL, et al
    Cost-effectiveness of a Household Salt Substitution Intervention: Findings From 20,995 Participants of the Salt Substitute and Stroke Study (SSaSS).
    Circulation. 2022 Mar 21. doi: 10.1161/CIRCULATIONAHA.122.059573.
    >> Share

  15. KOWALEWSKI C, Dagres N, Hindricks G
    Are 2 Left Atrial Appendage Guards Better Than 1? The Amulet IDE Randomized Trial.
    Circulation. 2022;145:739-741.
    >> Share

  16. LUBITZ SA, Atlas SJ, Ashburner JM, Trisini Lipsanopoulos AT, et al
    Screening for Atrial Fibrillation in Older Adults at Primary Care Visits: the VITAL-AF Randomized Controlled Trial.
    Circulation. 2022 Mar 2. doi: 10.1161/CIRCULATIONAHA.121.057014.
    >> Share

    February 2022
  17. HAUSLER KG, Eichner FA, Heuschmann PU, Fiebach JB, et al
    MRI-Detected Brain Lesions and Cognitive Function in Atrial Fibrillation Patients Undergoing Left Atrial Catheter Ablation in the Randomized AXAFA-AFNET 5 Trial.
    Circulation. 2022 Feb 9. doi: 10.1161/CIRCULATIONAHA.121.056320.
    >> Share

    January 2022
  18. TSAO CW, Aday AW, Almarzooq ZI, Alonso A, et al
    Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association.
    Circulation. 2022 Jan 26:CIR0000000000001052. doi: 10.1161/CIR.0000000000001052.
    >> Share

  19. AGUADO BA, Walker CJ, Grim JC, Schroeder ME, et al
    Genes that Escape X Chromosome Inactivation Modulate Sex Differences in Valve Myofibroblasts.
    Circulation. 2022 Jan 10. doi: 10.1161/CIRCULATIONAHA.121.054108.
    >> Share

    December 2021
  20. BAHNSON TD, Giczewska A, Mark DB, Russo AM, et al
    Association Between Age and Outcomes of Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: Results from the CABANA Trial.
    Circulation. 2021 Dec 22. doi: 10.1161/CIRCULATIONAHA.121.055297.
    >> Share

  21. ZHENG F, von Spreckelsen N, Hu W
    Letter by Zheng et al Regarding Article, "Efficacy and Safety of Using Dual Versus Monotherapy Antiplatelet Agents in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials".
    Circulation. 2021;144:e491-e492.
    >> Share

  22. TRIFAN G, Gorelick PB, Testai FD
    Response by Trifan et al to Letter Regarding Article, "Efficacy and Safety of Using Dual Versus Monotherapy Antiplatelet Agents in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials".
    Circulation. 2021;144:e493-e494.
    >> Share

    November 2021
  23. HANKEY GJ
    Embolic Stroke of Undetermined Source: Can We Identify Subgroups With High Risk for Atrial Fibrillation Who May Benefit From Oral Anticoagulation?
    Circulation. 2021;144:1747-1749.
    >> Share

  24. KIRCHHOF P
    In Patients With Recently Diagnosed Atrial Fibrillation, Think Anticoagulation and Rhythm Control.
    Circulation. 2021;144:1587-1589.
    >> Share

    October 2021
  25. VERMA S, Bhatt DL, Steg PG, Miller M, et al
    Icosapent Ethyl Reduces Ischemic Events in Patients with a History of Prior Coronary Artery Bypass Grafting: REDUCE-IT CABG.
    Circulation. 2021 Oct 28. doi: 10.1161/CIRCULATIONAHA.121.056290.
    >> Share

  26. MAJITHIA A, Bhatt DL, Friedman AN, Miller M, et al
    Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients with Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL.
    Circulation. 2021 Oct 28. doi: 10.1161/CIRCULATIONAHA.121.055560.
    >> Share

  27. KHAN SU, Javed Z, Lone AN, Dani SS, et al
    Social Vulnerability and Premature Cardiovascular Mortality Among US Counties, 2014 to 2018.
    Circulation. 2021;144:1272-1279.
    >> Share

  28. BAHIT MC, Sacco RL, Easton JD, Meyerhoff J, et al
    Predictors of Development of Atrial Fibrillation in Patients With Embolic Stroke Of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
    Circulation. 2021 Oct 15. doi: 10.1161/CIRCULATIONAHA.121.055176.
    >> Share

  29. HESS CN, Debus ES, Nehler MR, Anand SS, et al
    Reduction in Acute Limb Ischemia with Rivaroxaban versus Placebo in Peripheral Artery Disease after Lower Extremity Revascularization: Insights from VOYAGER PAD.
    Circulation. 2021 Oct 12. doi: 10.1161/CIRCULATIONAHA.121.055146.
    >> Share

    September 2021
  30. CHO SM, Mehaffey JH, Meyers SL, Cantor RS, et al
    Cerebrovascular Events in Patients With Centrifugal-Flow Left Ventricular Assist Devices: Propensity Score-Matched Analysis From the Intermacs Registry.
    Circulation. 2021;144:763-772.
    >> Share

    August 2021
  31. LAKKIREDDY D, Thaler D, Ellis CR, Swarup V, et al
    AMPLATZER AMULET LEFT ATRIAL APPENDAGE OCCLUDER VERSUS WATCHMAN DEVICE FOR STROKE PROPHYLAXIS (AMULET IDE): A RANDOMIZED CONTROLLED TRIAL.
    Circulation. 2021 Aug 30. doi: 10.1161/CIRCULATIONAHA.121.057063.
    >> Share

  32. LACKEY LG, Garnett CE, Senatore F
    Applying Decision Analysis to Inform the US Food and Drug Administration's Benefit-Risk Assessment of Ticagrelor for Primary Prevention of Myocardial Infarction or Stroke Based on THEMIS.
    Circulation. 2021;144:655-658.
    >> Share

  33. DEBUS ES, Nehler MR, Govsyeyev N, Bauersachs RM, et al
    Effect of Rivaroxaban and Aspirin in Patients with Peripheral Artery Disease Undergoing Surgical Revascularization: Insights from the VOYAGER PAD Trial.
    Circulation. 2021 Aug 12. doi: 10.1161/CIRCULATIONAHA.121.054835.
    >> Share

    July 2021
  34. RILLIG A, Magnussen C, Ozga AK, Suling A, et al
    Early Rhythm Control Therapy in Patients with Atrial Fibrillation and Heart Failure.
    Circulation. 2021 Jul 30. doi: 10.1161/CIRCULATIONAHA.121.056323.
    >> Share

    May 2021
  35. CRUMP C, Sundquist J, Sundquist K
    Preterm Delivery and Long-Term Risk of Stroke in Women: A National Cohort and Cosibling Study.
    Circulation. 2021 May 10. doi: 10.1161/CIRCULATIONAHA.120.052268.
    >> Share

    April 2021
  36. TRIFAN G, Gorelick PB, Testai FD
    Efficacy and Safety of Using Dual Versus Monotherapy Antiplatelet Agents in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.
    Circulation. 2021 Apr 30. doi: 10.1161/CIRCULATIONAHA.121.053782.
    >> Share

  37. BENESCH C, Glance LG, Derdeyn CP, Fleisher LA, et al
    Perioperative Neurological Evaluation and Management to Lower the Risk of Acute Stroke in Patients Undergoing Noncardiac, Nonneurological Surgery: A Scientific Statement From the American Heart Association/American Stroke Association.
    Circulation. 2021 Apr 8:CIR0000000000000968. doi: 10.1161/CIR.0000000000000968.
    >> Share

  38. KAR S, Doshi SK, Sadhu A, Horton R, et al
    Primary Outcome Evaluation of a Next Generation Left Atrial Appendage Closure Device: Results from the PINNACLE FLX Trial.
    Circulation. 2021 Apr 6. doi: 10.1161/CIRCULATIONAHA.120.050117.
    >> Share

  39. DOUMOURAS A, Wong JA, Paterson JM, Lee Y, et al
    Bariatric Surgery and Cardiovascular Outcomes in Patients With Obesity and Cardiovascular Disease: A Population-Based Retrospective Cohort Study.
    Circulation. 2021 Apr 5. doi: 10.1161/CIRCULATIONAHA.120.052386.
    >> Share

    March 2021
  40. SALEH C
    Letter by Saleh Regarding Article, "Carotid Atherosclerosis Evolution When Targeting a Low-Density Lipoprotein Cholesterol Concentration <70 mg/dL After an Ischemic Stroke of Atherosclerotic Origin".
    Circulation. 2021;143:e790-e791.
    >> Share

    February 2021
  41. BUTALA NM, Makkar R, Secemsky EA, Gallup D, et al
    Cerebral Embolic Protection and Outcomes of Transcatheter Aortic Valve Replacement: Results from the TVT Registry.
    Circulation. 2021 Feb 23. doi: 10.1161/CIRCULATIONAHA.120.052874.
    >> Share

  42. GOFF DC JR, Khan SS, Lloyd-Jones D, Arnett DK, et al
    Bending the Curve in Cardiovascular Disease Mortality: Bethesda + 40 and Beyond.
    Circulation. 2021;143:837-851.
    >> Share

  43. ELGENDY IY, Bukhari S, Barakat AF, Pepine CJ, et al
    Maternal Stroke: A Call for Action.
    Circulation. 2021;143:727-738.
    >> Share

  44. RAGHUNATH S, Pfeifer JM, Ulloa-Cerna AE, Nemani A, et al
    Deep Neural Networks Can Predict New-Onset Atrial Fibrillation From the 12-Lead Electrocardiogram and Help Identify Those at Risk of AF-Related Stroke.
    Circulation. 2021 Feb 16. doi: 10.1161/CIRCULATIONAHA.120.047829.
    >> Share

    January 2021
  45. VIRANI SS, Alonso A, Aparicio HJ, Benjamin EJ, et al
    Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association.
    Circulation. 2021 Jan 27:CIR0000000000000950. doi: 10.1161/CIR.0000000000000950.
    >> Share

  46. BENJAMIN EJ, Go AS, Desvigne-Nickens P, Anderson CD, et al
    Research Priorities in Atrial Fibrillation Screening: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop.
    Circulation. 2021;143:372-388.
    >> Share

  47. HIJAZI Z, Alexander JH, Li Z, Wojdyla DM, et al
    Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients with Atrial Fibrillation After Acute Coronary Syndrome or PCI: Insights from The AUGUSTUS Trial.
    Circulation. 2021 Jan 19. doi: 10.1161/CIRCULATIONAHA.120.051020.
    >> Share

  48. LI W, Kessinger CW, Orii M, Lee H, et al
    Time-Restricted Salutary Effects of Blood Flow Restoration on Venous Thrombosis and Vein Wall Injury in Mouse and Human Subjects.
    Circulation. 2021 Jan 15. doi: 10.1161/CIRCULATIONAHA.120.049096.
    >> Share

  49. SCHWARTZ GG, Steg PG, Bhatt DL, Bittner VA, et al
    Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES Trial.
    Circulation. 2021 Jan 13. doi: 10.1161/CIRCULATIONAHA.120.049447.
    >> Share

    December 2020
  50. KATSANOS AH, Kamel H, Healey JS, Hart RG, et al
    Stroke Prevention in Atrial Fibrillation: Looking Forward.
    Circulation. 2020;142:2371-2388.
    >> Share

  51. CHURCHWELL K, Elkind MSV, Benjamin RM, Carson AP, et al
    Call to Action: Structural Racism as a Fundamental Driver of Health Disparities: A Presidential Advisory From the American Heart Association.
    Circulation. 2020;142:e454-e468.
    >> Share

  52. SOGAARD M, Nielsen PB, Skjoth F, Eldrup N, et al
    Temporal Changes in Secondary Prevention and Cardiovascular Outcomes after Revascularization for Peripheral Arterial Disease in Denmark: A Nationwide Cohort Study.
    Circulation. 2020 Dec 10. doi: 10.1161/CIRCULATIONAHA.120.047994.
    >> Share

  53. SAFFORD MM, Reshetnyak E, Sterling MR, Richman JS, et al
    Number of Social Determinants of Health and Fatal and Nonfatal Incident Coronary Heart Disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
    Circulation. 2020 Dec 3. doi: 10.1161/CIRCULATIONAHA.120.048026.
    >> Share

    November 2020
  54. MARSTON NA, Patel PN, Kamanu FK, Nordio F, et al
    Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients with Cardiometabolic Disease.
    Circulation. 2020 Nov 13. doi: 10.1161/CIRCULATIONAHA.120.051927.
    >> Share

    October 2020
  55. AYTEKIN A, Ndrepepa G, Neumann FJ, Menichelli M, et al
    Ticagrelor or Prasugrel in Patients with ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Circulation. 2020 Oct 29. doi: 10.1161/CIRCULATIONAHA.120.050244.
    >> Share

  56. LOWENSTEIN CJ, Solomon SD
    Severe COVID-19 Is a Microvascular Disease.
    Circulation. 2020;142:1609-1611.
    >> Share

  57. MODIN D, Claggett B, Sindet-Pedersen C, Lassen MCH, et al
    Acute COVID-19 and the Incidence of Ischemic Stroke and Acute Myocardial Infarction.
    Circulation. 2020 Oct 15. doi: 10.1161/CIRCULATIONAHA.120.050809.
    >> Share

  58. TAMBURINO C, Bleiziffer S, Thiele H, Scholtz S, et al
    Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients with Symptomatic Severe Aortic Stenosis: The SCOPE 2 Randomized Clinical Trial.
    Circulation. 2020 Oct 15. doi: 10.1161/CIRCULATIONAHA.120.051547.
    >> Share

  59. BENEDETTO U, Gaudino MF, Dimagli A, Gerry S, et al
    Postoperative Atrial Fibrillation and Long-Term Risk of Stroke After Isolated Coronary Artery Bypass Graft Surgery.
    Circulation. 2020;142:1320-1329.
    >> Share

  60. DROBNI ZD, Alvi RM, Taron J, Zafar A, et al
    Association Between Immune Checkpoint Inhibitors with Cardiovascular Events and Atherosclerotic Plaque.
    Circulation. 2020 Oct 2. doi: 10.1161/CIRCULATIONAHA.120.049981.
    >> Share

    August 2020
  61. GAUDINO M, Benesch C, Bakaeen F, DeAnda A, et al
    Considerations for Reduction of Risk of Perioperative Stroke in Adult Patients Undergoing Cardiac and Thoracic Aortic Operations: A Scientific Statement From the American Heart Association.
    Circulation. 2020 Aug 26:CIR0000000000000885. doi: 10.1161/CIR.0000000000000885.
    >> Share

  62. BUTT JH, Fosbol EL, Ostergaard L, Yafasova A, et al
    The Impact of Coronavirus Disease 2019 (COVID-19) on First-time Acute Stroke and Transient Ischemic Attack Admission Rates and Prognosis in Denmark: A Nationwide Cohort Study.
    Circulation. 2020 Aug 5. doi: 10.1161/CIRCULATIONAHA.120.050173.
    >> Share

    July 2020
  63. LIBERALE L, Bonetti NR, Puspitasari YM, Schwarz L, et al
    Postischemic Administration of IL-1alpha Neutralizing Antibody Reduces Brain Damage and Neurological Deficit in Experimental Stroke.
    Circulation. 2020;142:187-189.
    >> Share

    June 2020
  64. AMARENCO P, Hobeanu C, Labreuche J, Charles H, et al
    Carotid Atherosclerosis Evolution when Targeting a Low-Density Lipoprotein Cholesterol Concentration < 70 mg/dL after an Ischemic Stroke of Atherosclerotic Origin.
    Circulation. 2020 Jun 29. doi: 10.1161/CIRCULATIONAHA.120.046774.
    >> Share

  65. WILLEIT P, Tschiderer L, Allara E, Reuber K, et al
    Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100,667 Patients.
    Circulation. 2020 Jun 17. doi: 10.1161/CIRCULATIONAHA.120.046361.
    >> Share

  66. LEE H, Yano Y, Cho SMJ, Park JH, et al
    Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults.
    Circulation. 2020;141:1778-1786.
    >> Share

    May 2020
  67. YANG L, Han B, Zhang Z, Wang S, et al
    Extracellular Vesicle-Mediated Delivery of CircSCMH1 Promotes Functional Recovery in Rodent and Nonhuman Primate Ischemic Stroke Models.
    Circulation. 2020 May 22. doi: 10.1161/CIRCULATIONAHA.120.045765.
    >> Share

  68. POTHINENI NVK, Deo R
    Screening for Atrial Fibrillation: Closing the "LOOP".
    Circulation. 2020;141:1523-1526.
    >> Share

    April 2020
  69. BETHEL MA, Stevens SR, Buse JB, Choi J, et al
    Exploring the Possible Impact of Unbalanced Open-Label Drop-In of Glucose-Lowering Medications on EXSCEL Outcomes.
    Circulation. 2020;141:1360-1370.
    >> Share

  70. CAINZOS-ACHIRICA M, Miedema MD, McEvoy JW, Al Rifai M, et al
    Coronary Artery Calcium for Personalized Allocation of Aspirin in Primary Prevention of Cardiovascular Disease in 2019: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Circulation. 2020 Apr 1. doi: 10.1161/CIRCULATIONAHA.119.045010.
    >> Share

    March 2020
  71. ALEXANDER JH, Wojdyla D, Vora AN, Thomas L, et al
    The Risk / Benefit Tradeoff of Antithrombotic Therapy in Patients with Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights from AUGUSTUS.
    Circulation. 2020 Mar 29. doi: 10.1161/CIRCULATIONAHA.120.046534.
    >> Share

  72. KAPLAN RM, Ziegler PD, Passman RS
    Response by Kaplan et al to Letter Regarding Article, "Stroke Risk as a Function of Atrial Fibrillation Duration and CHA2DS2-VASc Score".
    Circulation. 2020;141:e599-e600.
    >> Share

  73. CAO S, Zhu X, Xia M
    Letter by Cao et al Regarding Article, "Stroke Risk as a Function of Atrial Fibrillation Duration and CHA2DS2-VASc Score".
    Circulation. 2020;141:e597-e598.
    >> Share

  74. DIEDERICHSEN SZ, Haugan KJ, Kronborg C, Graff C, et al
    A Comprehensive Evaluation of Rhythm Monitoring Strategies in Screening for Atrial Fibrillation: Insights from Patients at Risk Long-Term Monitored with Implantable Loop Recorder.
    Circulation. 2020 Mar 2. doi: 10.1161/CIRCULATIONAHA.119.044407.
    >> Share

    February 2020
  75. KHOSROW-KHAVAR F, Filion KB, Bouganim N, Suissa S, et al
    Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer: A Population-Based Cohort Study.
    Circulation. 2020;141:549-559.
    >> Share

  76. HARRINGTON RA, Califf RM, Balamurugan A, Brown N, et al
    Call to Action: Rural Health: A Presidential Advisory From the American Heart Association and American Stroke Association.
    Circulation. 2020 Feb 10:CIR0000000000000753. doi: 10.1161/CIR.0000000000000753.
    >> Share

  77. BHATT DL, Miller M, Brinton EA, Jacobson TA, et al
    REDUCE-IT USA: Results From the 3146 Patients Randomized in the United States.
    Circulation. 2020;141:367-375.
    >> Share

    January 2020
  78. VIRANI SS, Alonso A, Benjamin EJ, Bittencourt MS, et al
    Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association.
    Circulation. 2020 Jan 29:CIR0000000000000757. doi: 10.1161/CIR.0000000000000757.
    >> Share

    November 2019
  79. SCHNABEL RB, Haeusler KG, Healey JS, Freedman B, et al
    Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration.
    Circulation. 2019;140:1834-1850.
    >> Share

  80. JIA X, Sun W, Hoogeveen RC, Nambi V, et al
    Response by Jia et al to Letter Regarding Article, "High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study".
    Circulation. 2019;140:e772-e773.
    >> Share

  81. LI D, Cheng Y
    Letter by Li and Cheng Regarding Article, "High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study".
    Circulation. 2019;140:e770-e771.
    >> Share

  82. MICHOS ED, Martin SS
    Achievement of Very Low Low-Density Lipoprotein Cholesterol Levels: Is It Time to Unlearn Concern for Hemorrhagic Stroke?
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044275.
    >> Share

  83. JUKEMA JW, Zijlstra LE, Bhatt DL, Bittner VA, et al
    Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.043826.
    >> Share

    September 2019
  84. KAPLAN RM, Koehler J, Ziegler PD, Sarkar S, et al
    Stroke Risk as a Function of Atrial Fibrillation Duration and CHA2DS2-VASc Score.
    Circulation. 2019 Sep 30. doi: 10.1161/CIRCULATIONAHA.119.041303.
    >> Share

  85. WATANABE H, Domei T, Morimoto T, Natsuaki M, et al
    Very Short Dual Antiplatelet Therapy after Drug-eluting Stent Implantation in Patients with High Bleeding Risk: Insight from the STOPDAPT-2 Trial.
    Circulation. 2019 Sep 27. doi: 10.1161/CIRCULATIONAHA.119.043613.
    >> Share

  86. NOLAN JP, Berg RA, Andersen LW, Bhanji F, et al
    Cardiac Arrest and Cardiopulmonary Resuscitation Outcome Reports: Update of the Utstein Resuscitation Registry Template for In-Hospital Cardiac Arrest: A Consensus Report From a Task Force of the International Liaison Committee on Resuscitation (Ameri
    Circulation. 2019 Sep 16:CIR0000000000000710. doi: 10.1161/CIR.0000000000000710.
    >> Share

  87. PLUMP A, Davey Smith G
    Identifying and Validating New Drug Targets for Stroke and Beyond.
    Circulation. 2019;140:831-835.
    >> Share

    August 2019
  88. SVEDBERG N, Sundstrom J, James S, Hallmarker U, et al
    Long-Term Incidence of Atrial Fibrillation and Stroke Among Cross-Country Skiers: Cohort Study of Endurance-Trained Male and Female Athletes.
    Circulation. 2019 Aug 26. doi: 10.1161/CIRCULATIONAHA.118.039461.
    >> Share

  89. PACKER M
    Reconceptualization of the Molecular Mechanism by Which Sodium-Glucose Cotransporter 2 Inhibitors Reduce the Risk of Heart Failure Events.
    Circulation. 2019;140:443-445.
    >> Share

    July 2019
  90. MEHRA MR, Colombo PC
    Response by Mehra and Colombo to Letter Regarding Article, "Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study: A Randomized Controlled Trial of the Heartmate 3 Versus the Heartmate II Cardiac Pump".
    Circulation. 2019;140:e165-e166.
    >> Share

  91. CONSOLO F, Pappalardo F
    Letter by Consolo and Pappalardo Regarding Article, "Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study: A Randomized Controlled Trial of the Heartmate 3 Versus the Heartmate II Cardiac Pump".
    Circulation. 2019;140:e163-e164.
    >> Share

    June 2019
  92. CHONG M, Sjaarda J, Pigeyre M, Mohammadi-Shemirani P, et al
    Novel Drug Targets for Ischemic Stroke Identified Through Mendelian Randomization Analysis of the Blood Proteome.
    Circulation. 2019 Jun 18. doi: 10.1161/CIRCULATIONAHA.119.040180.
    >> Share

    April 2019
  93. WANG TY
    Effectively Initiating and Maintaining Anticoagulation in Patients With Atrial Fibrillation.
    Circulation. 2019;139:1763-1765.
    >> Share

    March 2019
  94. SHAH S, Xian Y, Sheng S, Zachrison KS, et al
    Use, Temporal Trends, and Outcomes of Endovascular Therapy After Interhospital Transfer in the United States.
    Circulation. 2019;139:1568-1577.
    >> Share

    February 2019
  95. NAFEE T, Gibson CM, Yee MK, Kerneis M, et al
    Reduction of Cardiovascular Mortality and Ischemic Events in Acute Medically Ill Patients.
    Circulation. 2019;139:1234-1236.
    >> Share

  96. HANKEY GJ
    Antithrombotic Therapy for Stroke Prevention.
    Circulation. 2019;139:1131-1133.
    >> Share

  97. CHUNG J, Stevens LM, Ouzounian M, El-Hamamsy I, et al
    Sex-Related Differences in Patients Undergoing Thoracic Aortic Surgery.
    Circulation. 2019;139:1177-1184.
    >> Share

  98. HYLEK EM
    Biomarkers for Prediction of Stroke and Bleeds in Atrial Fibrillation.
    Circulation. 2019;139:772-774.
    >> Share

    January 2019
  99. PICCINI JP, Xu H, Cox M, Matsouaka RA, et al
    Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).
    Circulation. 2019 Jan 31. doi: 10.1161/CIRCULATIONAHA.118.035909.
    >> Share

  100. BENJAMIN EJ, Muntner P, Alonso A, Bittencourt MS, et al
    Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.
    Circulation. 2019 Jan 31:CIR0000000000000659. doi: 10.1161/CIR.0000000000000659.
    >> Share

  101. SHARMA M, Hart RG, Connolly SJ, Bosch J, et al
    Stroke Outcomes in the Cardiovascular OutcoMes for People using Anticoagulation StrategieS (COMPASS) Trial.
    Circulation. 2019 Jan 22. doi: 10.1161/CIRCULATIONAHA.118.035864.
    >> Share

  102. OKAZAKI S, Morimoto T, Kamatani Y, Kamimura T, et al
    Moyamoya Disease Susceptibility Variant RNF213 p.R4810K Increases the Risk of Ischemic Stroke Attributable to Large-Artery Atherosclerosis.
    Circulation. 2019;139:295-298.
    >> Share

  103. SCHWAMM LH
    Digital Health Strategies to Improve Care and Continuity Within Stroke Systems of Care in the United States.
    Circulation. 2019;139:149-151.
    >> Share

    December 2018
  104. MANN JFE, Fonseca V, Mosenzon O, Raz I, et al
    Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease.
    Circulation. 2018;138:2908-2918.
    >> Share

  105. VERMA S, Poulter NR, Bhatt DL, Bain SC, et al
    Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke.
    Circulation. 2018;138:2884-2894.
    >> Share

  106. DIDIER R, Eltchaninoff H, Donzeau-Gouge P, Chevreul K, et al
    Five-Year Clinical Outcome and Valve Durability After Transcatheter Aortic Valve Replacement in High-Risk Patients.
    Circulation. 2018;138:2597-2607.
    >> Share

  107. KIM MK, Han K, Park YM, Kwon HS, et al
    Associations of Variability in Blood Pressure, Glucose and Cholesterol Concentrations, and Body Mass Index With Mortality and Cardiovascular Outcomes in the General Population.
    Circulation. 2018;138:2627-2637.
    >> Share

    November 2018
  108. SAVITZ SI, Yavagal D, Rappard G, Likosky W, et al
    A Phase 2 Randomized, Sham Controlled Trial of Internal Carotid Artery Infusion of Autologous Bone Marrow Derived ALD-401 Cells in Patients with Recent Stable Ischemic Stroke (RECOVER-Stroke).
    Circulation. 2018 Nov 29. doi: 10.1161/CIRCULATIONAHA.117.030659.
    >> Share

  109. BASSAND JP, Virdone S, Goldhaber SZ, Camm AJ, et al
    Early Risks of Death, Stroke/Systemic Embolism and Major Bleeding in Patients with Newly Diagnosed Atrial Fibrillation: Results from the GARFIELD-AF Registry.
    Circulation. 2018 Nov 28. doi: 10.1161/CIRCULATIONAHA.118.035012.
    >> Share

  110. BERG DD, Ruff CT, Jarolim P, Giugliano RP, et al
    Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients with Atrial Fibrillation in ENGAGE AF-TIMI 48.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038312.
    >> Share

  111. ROCHA RV, Tam DY, Karkhanis R, Nedadur R, et al
    Multiple Arterial Grafting Is Associated With Better Outcomes for Coronary Artery Bypass Grafting Patients.
    Circulation. 2018;138:2081-2090.
    >> Share

    October 2018
  112. DI BIASE L, Natale A, Romero J
    Thrombogenic and Arrhythmogenic Roles of the Left Atrial Appendage in Atrial Fibrillation.
    Circulation. 2018;138:2036-2050.
    >> Share

  113. KHERA A, Budoff MJ, O'Donnell CJ, Ayers CA, et al
    Astronaut Cardiovascular Health and Risk Modification (Astro-CHARM) Coronary Calcium Atherosclerotic Cardiovascular Disease Risk Calculator.
    Circulation. 2018;138:1819-1827.
    >> Share

  114. CHAO TF, Chiang CE, Lin YJ, Chang SL, et al
    Evolving Changes of the Use of Oral Anticoagulants and Outcomes in Patients With Newly Diagnosed Atrial Fibrillation in Taiwan.
    Circulation. 2018;138:1485-1487.
    >> Share

  115. MAHESHWARI A, Norby FL, Roetker NS, Soliman EZ, et al
    Refining Prediction of Atrial Fibrillation-Related Stroke Using the P2-CHA2DS2-VASc Score: The Atherosclerosis Risk in Communities (ARIC) Study and Multi-Ethnic Study of Atherosclerosis (MESA).
    Circulation. 2018 Oct 2. doi: 10.1161/CIRCULATIONAHA.118.035411.
    >> Share

    September 2018
  116. DAWSON J
    Pioglitazone Use After Stroke.
    Circulation. 2018;138:1221-1223.
    >> Share

  117. KOH KK
    Letter by Koh Regarding Article, "PCSK9 Variants, Low-Density Lipoprotein Cholesterol, and Neurocognitive Impairment: Reasons for Geographic and Racial Differences in Stroke Study (REGARDS)".
    Circulation. 2018;138:1283-1284.
    >> Share

  118. DE VEER AJWM, Bennaghmouch N, Mahmoodi BK, Ten Berg JM, et al
    Response by de Veer et al to Letter Regarding Article, "Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Tria
    Circulation. 2018;138:1279.
    >> Share

  119. TONG S, Zhang L, Joseph J
    Letter by Tong et al Regarding Article, "Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials".
    Circulation. 2018;138:1277-1278.
    >> Share

  120. COLOMBO PC, Mehra MR, Goldstein DJ, Estep JD, et al
    Comprehensive Analysis of Stroke in the LongTerm Cohort of the MOMENTUM 3 Study: A Randomized Controlled Trial of the HeartMate 3 Versus the HeartMate II Cardiac Pump.
    Circulation. 2018 Sep 17. doi: 10.1161/CIRCULATIONAHA.118.037231.
    >> Share

    July 2018
  121. SHEN YM, Nagalla S
    Hypercoagulable Workup in Thrombotic Cardiovascular Diseases.
    Circulation. 2018;138:229-231.
    >> Share

    June 2018
  122. YOUNG LH, Viscoli CM, Schwartz GG, Inzucchi SE, et al
    Heart Failure After Ischemic Stroke or TIA in Insulin-Resistant Patients Without Diabetes Treated with Pioglitazone.
    Circulation. 2018 Jun 22. pii: CIRCULATIONAHA.118.034763.
    >> Share

  123. SHARMA A, Hijazi Z, Andersson U, Al-Khatib SM, et al
    The Use of Biomarkers to Predict Specific Causes of Death in Patients with Atrial Fibrillation: Insights from the ARISTOTLE Trial.
    Circulation. 2018 Jun 5. pii: CIRCULATIONAHA.118.034125.
    >> Share

    May 2018
  124. MEHRA MR, Salerno C, Cleveland JC, Pinney S, et al
    Health Care Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study: A Randomized Controlled Trial of a Magnetically Levitated Cardiac Pump in Advanced Heart Failure.
    Circulation. 2018 May 27. pii: CIRCULATIONAHA.118.035722.
    >> Share

  125. NAZHA B, Pandya B, Cohen J, Zhang M, et al
    Periprocedural Outcomes of Direct Oral Anticoagulants vs. Warfarin in Non-Valvular Atrial Fibrillation: A Meta-analysis of Phase III Trials.
    Circulation. 2018 May 24. pii: CIRCULATIONAHA.117.031457.
    >> Share

    April 2018
  126. O'BRIEN EC, Holmes DN, Thomas LE, Fonarow GC, et al
    Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients with Atrial Fibrillation.
    Circulation. 2018 Apr 20. pii: CIRCULATIONAHA.117.031354.
    >> Share

    March 2018
  127. BEHESHTI S, Madsen CM, Varbo A, Benn M, et al
    Relationship of Familial Hypercholesterolemia and High LDL Cholesterol to Ischemic Stroke: The Copenhagen General Population Study.
    Circulation. 2018 Mar 28. pii: CIRCULATIONAHA.118.033470.
    >> Share

    February 2018
  128. CHAO TF, Liu CJ, Lin YJ, Chang SL, et al
    Oral Anticoagulation in Very Elderly Patients with Atrial Fibrillation - A Nationwide Cohort Study.
    Circulation. 2018 Feb 28. pii: CIRCULATIONAHA.117.031658.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016